NBNatasha Berthold

Natasha Berthold

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Natasha Berthold has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From Genomes to Conversations: Outreach and Engagement in Psychiatric Genetics

    by Helena L. Davies, Niamh M. Ryan, Kylie K. Reed, Natasha Berthold, Jared G. Maina, Ruth McNulty, Abigail R. ter Kuile, Ofure A. Ubah, Eva Trujillo-ChiVacuan, Eva C. Schulte, et al.

    Outreach in psychiatric genetics bridges the gaps across research advancements, clinical practice, and public understanding. Effective communication with a range of audiences faces multiple challenges, including the complex nature of psychiatric disorders and of genetic findings, the chronicled and ongoing misuse of genetic data, and the rapid growth of direct-to-consumer genetic testing. This is particularly true in the internet and social media era, which has accelerated the spread of inaccurate information with serious consequences, including perpetuating stigma and increasing shame. Yet a significant gap remains in outreach: a recent survey found that only 51% of psychiatric genetics researchers participate in outreach, largely attributed to their perceived lack of skill and support. The Psychiatric Genomics Consortium (PGC) developed an Outreach Committee to organize and catalyze initiatives including: the Worldwide Lab, an online seminar series covering new and important approaches that is then posted on YouTube; the PGC Video Textbook, which has resources for clinicians, researchers, educators, and the broader public; patient and family engagement programs; and social media campaigns designed to inform both researchers and affected communities about new developments in psychiatric genetics. These initiatives were developed to demystify psychiatric genetics research and empower broad audiences with reliable, actionable information. Along with research and traditional teaching, the psychiatric genomics community should continue to prioritize and recognize engagement as a core component of our academic mission and values.


  • Open Access

    Multiple Psychiatric Traits Enriched for Brain Tissues in the Early Postpartum Period

    by Natasha Berthold, Shuyang Yao, Jerry Guintivano

    Background The perinatal period is a high-risk time for onset of various psychiatric disorders. However, it is unclear how genetic risk factors for these disorders interact with biological changes associated with pregnancy and postpartum. This study evaluates whether psychiatric genome-wide association study (GWAS) results are enriched within various brain regions across the perinatal period. Methods Tissue-specific enrichment analyses were conducted to estimate the potential impact of GWAS loci on transcriptional changes in the brain across the perinatal period. GWAS summary statistics were obtained for 26 psychiatric phenotypes. RNA-sequencing data was acquired from four brain regions (hypothalamus, hippocampus, cerebellum, and neocortex) in mice at six timepoints (virgin, 14- and 16-days post-conception, and 1-, 3- and 10-days postpartum). Results Hippocampus and neocortex in the early postpartum period are significantly enriched (q-value < 0.05) for genetic variants associated with schizophrenia (SCZ), bipolar disorder (BD), depressive symptoms, and major depressive disorder with suicidal features. The most significant enrichment occurred in the neocortex for SCZ and BD, peaking at postpartum day 1 (SCZ p-value = 3.85 × 10-8; BD p-value = 6.65 × 10-5). In the hippocampus, BD and SCZ were enriched at postpartum day 1 (SCZ p-value = 3.27 × 10-3; BD p-value = 4.33 × 10-3). No enrichment was observed in cerebellum or hypothalamus for any of the psychiatric traits tested. Conclusions The results accord with previous epidemiological studies and provide context in which to interpret GWAS results. Understanding the burden of genetic variants across the perinatal period may help prioritise pathways underlying onset of psychiatric disorders outside of pregnancy and postpartum periods.

  • Open Access

    The Eating Disorders Genetics Initiative 2 (EDGI2): Study Protocol

    by Cynthia Bulik, Natasha Berthold, Casey MacDermod, Laura Thornton, Richard Parker, Shantal Anid Cortés Morales, Liv Hog, Hannah Kennedy, Jerry Guintivano, Patrick F. Sullivan, et al.

    Background: The Eating Disorders Genetics Initiative 2 (EDGI2) is designed to explore the role of genes and environment in anorexia nervosa, bulimia nervosa, binge-eating disorder, and avoidant/restrictive food intake disorder (ARFID) with a focus on diverse populations and severe and/or longstanding illness.Methods: A total of 20,000 new participants (18,700 cases and 1,300 controls) will be ascertained from the United States (US), Mexico (MX), Australia (AU), Aotearoa New Zealand (NZ), Sweden (SE), and Denmark (DK). Comprehensive phenotyping and genotyping will be performed for participants in US, MX, AU, NZ, and SE using the EDGI2 questionnaire battery and participant saliva samples. In DK, case identification and genotyping will be through the National Patient Register and bloodspots archived near birth. Case-control and case-case genome-wide association studies will be conducted within EDGI2 and enhanced via meta-analysis with external data from the Eating Disorders Working Group of the Psychiatric Genomics Consortium (PGC-ED). Additional analyses will explore genetic correlations between eating disorders (EDs) and other psychiatric and metabolic traits, calculate polygenic risk scores (PRS), and leverage functional biology to evaluate clinical outcomes. Moreover, analyzing PRS for patient stratification and linking identified risk loci to clinically relevant phenotypes highlight the potential of EDGI2 for clinical translation. Discussion: EDGI2 is a global expansion of the EDGI study to increase sample size, expand the numbers of participants from non-European ancestry, and to include ARFID. Inclusion of MX will be the first large-scale ED genetics study from Latin America. ED genetics research has historically lagged behind other psychiatric disorders, and EDGI2 is designed to rapidly advance the study of the genetics of the major EDs. Exploring EDs at both the diagnostic level and the symptom level will provide an unprecedented look at the genetic architecture underlying EDs.

  • Open Access

    Bridging the gap: Short structural variants in the genetics of anorexia nervosa

    by Natasha Berthold, Julia Pytte, Cynthia M. Bulik, Monika Tschochner, Sarah E. Medland, Patrick Anthony Akkari

    Anorexia nervosa (AN) is a devastating disorder with evidence of underexplored heritability. Twin and family studies estimate heritability (h2) to be 57%–64%, and genome‐wide association studies (GWAS) reveal significant genetic correlations with psychiatric and anthropometric traits and a total of nine genome‐wide significant loci. Whether significantly associated single nucleotide polymorphisms identified by GWAS are causal or tag true causal variants, remains to be elucidated. We propose a novel method for bridging this knowledge gap by fine‐mapping short structural variants (SSVs) in and around GWAS‐identified loci. SSV fine‐mapping of loci associated with complex disorders such as schizophrenia, amyotrophic lateral sclerosis, and Alzheimer's disease has uncovered genetic risk markers, phenotypic variability between patients, new pathological mechanisms, and potential therapeutic targets. We analyze previous investigations' methods and propose utilizing an evaluation algorithm to prioritize 10 SSVs for each of the top two AN GWAS‐identified loci followed by Sanger sequencing and fragment analysis via capillary electrophoresis to characterize these SSVs for case/control association studies. Success of previous SSV analyses in complex disorders and effective utilization of similar methodologies supports our proposed method. Furthermore, the structural and spatial properties of the 10 SSVs identified for each of the top two AN GWAS‐associated loci, cell adhesion molecule 1 (CADM1) and NCK interacting protein with SH3 domain (NCKIPSD), are similar to previous studies. We propose SSV fine‐mapping of AN‐associated loci will identify causal genetic architecture. Deepening understandings of AN may lead to novel therapeutic targets and subsequently increase quality‐of‐life for individuals living with the illness.Public Significance Statement: Anorexia nervosa is a severe and complex illness, arising from a combination of environmental and genetic factors. Recent studies estimate the contribution of genetic variability; however, the specific DNA sequences and how they contribute remain unknown. We present a novel approach, arguing that the genetic variant class, short structural variants, could answer this knowledge gap and allow development of biologically targeted therapeutics, improving quality‐of‐life and patient outcomes for affected individuals.